Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European...

|About: Alnylam Pharmaceuticals,... (ALNY)|By:, SA News Editor

Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European Medicines Agency for its ALN-TTR01, an RNAi therapeutic. (PR)